CPHL logo

Citi Pharma Limited Stock Price

KASE:CPHL Community·PK₨22.7b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 17 Fair Values set on narratives written by author

CPHL Share Price Performance

PK₨96.26
58.48 (154.79%)
PK₨96.26
58.48 (154.79%)
Price PK₨96.26

CPHL Community Narratives

There are no narratives available yet.

Recent CPHL News & Updates

Citi Pharma Limited Key Details

PK₨13.0b

Revenue

PK₨11.3b

Cost of Revenue

PK₨1.7b

Gross Profit

PK₨868.4m

Other Expenses

PK₨830.9m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
3.64
Gross Margin
13.10%
Net Profit Margin
6.40%
Debt/Equity Ratio
52.4%

Citi Pharma Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
1 Reward

About CPHL

Founded
2012
Employees
519
CEO
Rizwan Ahmad
WebsiteView website
www.citipharma.com.pk

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

Pakistani Market Performance

  • 7 Days: 3.0%
  • 3 Months: 22.0%
  • 1 Year: 78.4%
  • Year to Date: 31.1%
Over the last 7 days, the market has risen 3.0%, driven by gains of 8.8% in the Financials sector. In the last year, the market has climbed 78%. Earnings are forecast to grow by 11% annually. Market details ›